‘

IGF-1 LR3 (1-Methylcyclohexyl) 1mg

IGF-1 LR3 (1-Methylcyclohexyl) is a chemically modified variant of Insulin-like Growth Factor 1 (IGF-1), designed to enhance its stability and longevity in biological systems. This peptide is frequently studied in the research context for its potential effects on cellular signaling pathways, particularly in investigations into tissue regeneration, muscle protein synthesis, and metabolic processes. As a research-use-only product, IGF-1 LR3 is intended for laboratory testing and academic inquiry only.

IGF-1 LR3 has been evaluated for its role in modulating growth factors and protein synthesis mechanisms. The modification with the 1-Methylcyclohexyl group helps prevent rapid degradation by proteases, thereby extending its half-life in vitro and potentially influencing downstream biological responses. This characteristic makes it valuable for studies examining sustained signaling effects and tissue repair.

Research Overview

IGF-1 LR3 has been extensively explored in both in vitro and in vivo models for its ability to exert prolonged biological activity. Research indicates that this modification can significantly enhance the peptide’s resistance to enzymatic cleavage, allowing for prolonged exposure to target tissues. Studies have examined its effects on muscle regeneration, cellular proliferation, and metabolic regulation, contributing to a deeper understanding of its potential applications in basic science research.

Key Research Focus Areas

• Cellular Signaling Pathways: Investigation of IGF-1 LR3’s role in activating growth factor receptors and downstream signaling cascades, including Akt/mTOR and MAPK pathways, in various tissue types.
• Muscle Protein Synthesis and Regeneration: Evaluation of its impact on muscle fiber growth, repair, and resistance to atrophy, particularly in preclinical models of muscle degradation or atrophy-related conditions.
• Tissue Repair and Regeneration: Examination of IGF-1 LR3’s potential in accelerating tissue repair processes, including cartilage, bone, and soft tissue regeneration, through prolonged biological activity.
• Metabolic Regulation: Analysis of its effects on glucose metabolism, lipid homeostasis, and energy balance in research models, contributing to studies on aging and metabolic diseases.
• Protein Stability and Half-Life Extension: Characterization of how the 1-Methylcyclohexyl modification enhances IGF-1 LR3’s resistance to proteolytic degradation, improving its utility in prolonged exposure studies.

It is important to note that the biological effects of IGF-1 LR3 are highly dependent on experimental conditions, including dosing, delivery methods, and study models. Researchers should conduct thorough validation to ensure accurate interpretation of results in their specific experimental contexts.

For research use only. Not for human or animal consumption. This product is intended solely for academic and laboratory research purposes and should only be handled by qualified professionals adhering to established safety protocols and regulatory guidelines applicable to peptide research materials.